Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05789095
Other study ID # H-20072873
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 28, 2023
Est. completion date April 30, 2023

Study information

Verified date January 2024
Source Hvidovre University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Osgood-Schlatter is a growth-related condition involving multiple different types of tissue in the tendon-bone interface at the tibial tubercle. Osgood-Schlatter affects one in ten adolescents causing persistent pain and reduced ability to maintain physical activities. Changes in rate of torque development is associated with decreased neuromuscular functioning and pain chronicity, thereby affecting athletic performances and general physical activities. However, changes in rate of torque development has not been investigate in patients with Osgood-Schlatter and could help characterize the condition and guide management. The aim of the study is to investigate early and peak rate of torque development during maximal voluntary isometric knee extension and knee flexion in adolescents with Osgood-Schlatter, compared to a matched group of asymptomatic adolescents (controls), in a cross-sectional study. The study will include 13 adolescent participants with Osgood-Schlatter and a group of 13 pain free controls matched on sex, age, and sports participation on the group level. Testing will include rate of torque measurements of knee extension and flexion for each limb with a fixated handheld dynamometer during a single test-session lasting approximately two hours. The examiner responsible for strength-testing will be blinded to case-status. Along with anthropometric data, participants will perform the anterior knee pain provocation test to assess pain-response to sustained knee loading, a countermovement jump test to assess power and jump height, and provide patient-reported measures of condition severity, pain, disability, and quality of life. Data collection will start March 2023 and is expected to finish by May 2023.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date April 30, 2023
Est. primary completion date April 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 9 Years to 16 Years
Eligibility Inclusion Criteria: - Patients must be 9-16 years of age - Presence of pain for 12 weeks or more - Pain at tibial tubercle during loading activities - Palpable pain at the tibial tuberosity Exclusion Criteria: - Previous knee or hip surgery - Other main diagnose of anterior knee pain (patellofemoral pain, Sinding-Larsen Johansson disease, Jumpers knee, etc.) - Hip and/or back pain interfering with activities of daily living or physical activities - Suspicion of other main diagnose such as meniscal tears and or ligamental tears - Unable to communicate verbally or orally in Danish

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Rate of torque development testing of knee flexors and knee extensors using a fixated handheld dynamometer (MicroFet 2, Hoggan, Scientific L.L.C., Salt Lake City, USA), sampling rate of 100hz)
Participants and their parents/guardian receives information about the test procedures. Written informed consent is obtained before clinical examination and testing. Clinical testing is performed, anthropometric values are obtained and patient reported outcome measure is filled out, before the tests are performed. Cases will receive treatment for their condition and controls a movie ticket as compensation.

Locations

Country Name City State
Denmark Hvidovre Hospital Hvidovre

Sponsors (1)

Lead Sponsor Collaborator
Hvidovre University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Knee osteoarthritis Outcome Score for children (KOOS Child) The scale contains 7 questions answered through a 0-4 likert scale. The scale is normalized to a 0-100 score, with zero representing extreme knee problems and 100 representing no knee problems.
In this study participants will fill out questions from the subscales "sport/rec", "quality of life" and question P1, P4, P6b and P6b from the "pain" subscale.
Day 1
Other The Tampa Scale 17 (TSK-17) The Tampa Scale is a 17-item questionnaire to evaluate fear avoidance behaviour in patients experiencing pain. It consists of two subscales on activity avoidance and somatic focus. The questions are rated on a 1-4 likert scale by the patient. The sum of the points are ranged from 17-68, with above 37 points being defined as "high level" of kinesiophobia. Day 1
Other Duration of pain Participants self-reported duration of pain denoted in months Day 1
Other Worst pain in the last week The perceived pain in the last week, rated on the Numerical Pain Rating scale, 0-10 with 0 being no pain and 10 being worst imaginable. Day 1
Other Worst pain in the last 24 hours The perceived pain in the last 24 hours, rated on the Numerical Pain Rating scale, 0-10 with 0 being no pain and 10 being worst imaginable. Day 1
Other Current pain The participants current pain on the Numerical Pain Rating scale, 0-10 with 0 being no pain and 10 being worst imaginable. Day 1
Other Counter Movement Jump Test The participants will perform three trials of a countermovement jump which will be recorded on a smartphone camera (>240 frames per second). Subsequently, it will be analyzed for jump height using the MyJump 2 smartphone application. Day 1
Other Counter Movement Jump Test The participants will perform three trials of a countermovement jump which will be recorded on a smartphone camera (>240 frames per second). Subsequently, it will be analyzed for power (W) using the MyJump 2 smartphone application. Day 1
Other Pain during Counter Movement Jump Test The participants will perform three trials of a countermovement jump. The pain during each jump will be rated on the 0-10 Numerical Pain Rating scale, 0-10 with 0 being no pain and 10 being worst imaginable. Day 1
Other Anterior Knee Pain Provocation test The participants will perform the Anterior Knee Pain Provocation test and rate the pain on the 0-10 Numerical Pain Rating Scale before and after the test. Only the affected knee is tested. For controls, the affected knee will be decided by coin toss. Day 1
Other Level of sports- participation and performance compared to before knee pain Participants are asked if they perform either 1) at a higher level than before onset of knee pain, 2) at the same level as before onset of knee pain, or 3) at a lower level than before onset of knee pain Day 1
Other Level of physical activity compared to before knee pain Participants are asked if they are either 1) more physically active than before onset of knee pain, 2) just as physically active as before onset of knee pain, or 3) are less physically active as before onset of knee pain Day 1
Primary Rate of torque development (Nm/s/kg) at 0-200 ms during maximal isometric knee extension Test performed seated on an examination bed with a belt-fixated handheld dynamometer (MicroFet 2, Hoggan Scientific, USA) at 60 degrees of knee flexion during a 5 second maximal exertion. Day 1
Primary Rate of torque development (Nm/s/kg) at 0-100 ms during maximal isometric knee extension Test performed seated on an examination bed with a belt-fixated handheld dynamometer (MicroFet 2, Hoggan Scientific, USA) at 60 degrees of knee flexion during a 5 second maximal exertion. Day 1
Primary Peak rate of torque development (Nm/s/kg) during maximal isometric knee extension Test performed seated on an examination bed with a belt-fixated handheld dynamometer (MicroFet 2, Hoggan Scientific, USA) at 60 degrees of knee flexion during a 5 second maximal exertion. Day 1
Primary Time to peak force, during maximal isometric knee extension Test performed seated on an examination bed with a belt-fixated handheld dynamometer (MicroFet 2, Hoggan Scientific, USA) at 60 degrees of knee flexion during a 5 second maximal exertion. Day 1
Primary Rate of torque development (Nm/s/kg) at 0-200 ms during maximal isometric knee flexion Test performed seated on an examination bed with a belt-fixated handheld dynamometer (MicroFet 2, Hoggan Scientific, USA) at 20 degrees of knee flexion during a 5 second maximal exertion. Day 1
Primary Rate of torque development (Nm/s/kg) at 0-100 ms during maximal isometric knee flexion Test performed seated on an examination bed with a belt-fixated handheld dynamometer (MicroFet 2, Hoggan Scientific, USA) at 20 degrees of knee flexion during a 5 second maximal exertion. Day 1
Primary Peak rate of torque development (Nm/s/kg) during maximal isometric knee flexion Test performed seated on an examination bed with a belt-fixated handheld dynamometer (MicroFet 2, Hoggan Scientific, USA) at 20 degrees of knee flexion during a 5 second maximal exertion. Day 1
Secondary Pain during strength testing (NRS 10) Numerical Pain Rating scale, 0-10 with 0 being no pain and 10 being worst imaginable. Day 1
See also
  Status Clinical Trial Phase
Completed NCT04716608 - Treatment for Osgood Schlatter Patients With a Physiotherapy Program N/A
Completed NCT03589001 - 24 Month Follow-up of Patients With Osgood Schlatter (OSD)
Recruiting NCT05826340 - Getting Kids With Osgood Schlatter Back to Performing Without Pain N/A
Completed NCT01300754 - Effectiveness of Dextrose Injection for Osgood-Schlatter Disease Phase 1/Phase 2
Active, not recruiting NCT05174182 - A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter N/A